HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Elizabeth Kieras Selected Research

PF-06700841

1/2020Molecular and Cellular Responses to the TYK2/JAK1 Inhibitor PF-06700841 Reveal Reduction of Skin Inflammation in Plaque Psoriasis.
1/2018The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a TYK2/JAK1 Inhibitor (PF-06700841) in Healthy Subjects and Patients With Plaque Psoriasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Elizabeth Kieras Research Topics

Disease

2Psoriasis (Pustulosis Palmaris et Plantaris)
01/2020 - 01/2018
1COVID-19
01/2021
1Inflammation (Inflammations)
01/2020

Drug/Important Bio-Agent (IBA)

2CytokinesIBA
01/2021 - 01/2020
2PF-06700841IBA
01/2020 - 01/2018
1Janus Kinase 1IBA
01/2020
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
01/2020
1Interleukin-17 (Interleukin 17)IBA
01/2020